C.M. Pirie

1.4k total citations
15 papers, 986 citations indexed

About

C.M. Pirie is a scholar working on Orthopedics and Sports Medicine, Molecular Biology and Genetics. According to data from OpenAlex, C.M. Pirie has authored 15 papers receiving a total of 986 indexed citations (citations by other indexed papers that have themselves been cited), including 9 papers in Orthopedics and Sports Medicine, 8 papers in Molecular Biology and 8 papers in Genetics. Recurrent topics in C.M. Pirie's work include Bone health and osteoporosis research (9 papers), Estrogen and related hormone effects (7 papers) and Bone Metabolism and Diseases (6 papers). C.M. Pirie is often cited by papers focused on Bone health and osteoporosis research (9 papers), Estrogen and related hormone effects (7 papers) and Bone Metabolism and Diseases (6 papers). C.M. Pirie collaborates with scholars based in United States. C.M. Pirie's co-authors include David D. Thompson, Hollis A. Simmons, H.Z. Ke, David T. Crawford, W.S.S. Jee, Hua Zhu Ke, Kristin L. Chidsey-Frink, Hongyi Qi, Y.F. Ma and Lydia C. Pan and has published in prestigious journals such as Circulation, Endocrinology and Journal of Pharmacology and Experimental Therapeutics.

In The Last Decade

C.M. Pirie

15 papers receiving 956 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
C.M. Pirie United States	12	404	394	390	238	227	15	986
J Cortés-Prieto Spain	11	169 0.4×	433 1.1×	80 0.2×	222 0.9×	161 0.7×	31	772
Valentina Martineti Italy	13	196 0.5×	230 0.6×	22 0.1×	61 0.3×	179 0.8×	21	610
Tomoyo Kawakubo‐Yasukochi Japan	14	303 0.8×	39 0.1×	95 0.2×	99 0.4×	87 0.4×	29	588
Hirofumi Shigeta Japan	14	183 0.5×	99 0.3×	42 0.1×	195 0.8×	89 0.4×	24	692
Xiao‐Ming Mao China	15	248 0.6×	78 0.2×	39 0.1×	318 1.3×	74 0.3×	45	707
Won Gu Jang South Korea	9	524 1.3×	44 0.1×	56 0.1×	173 0.7×	109 0.5×	12	810
D Hoffmann Germany	14	196 0.5×	56 0.1×	97 0.2×	95 0.4×	168 0.7×	40	655
Xiaojun Chen China	13	388 1.0×	39 0.1×	121 0.3×	26 0.1×	139 0.6×	38	798
Yuehu Han China	13	467 1.2×	26 0.1×	87 0.2×	34 0.1×	137 0.6×	22	782
Michel Brazier France	13	229 0.6×	38 0.1×	57 0.1×	24 0.1×	63 0.3×	32	593

Countries citing papers authored by C.M. Pirie

Since Specialization

Citations

This map shows the geographic impact of C.M. Pirie's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by C.M. Pirie with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites C.M. Pirie more than expected).

Fields of papers citing papers by C.M. Pirie

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by C.M. Pirie. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by C.M. Pirie. The network helps show where C.M. Pirie may publish in the future.

Co-authorship network of co-authors of C.M. Pirie

This figure shows the co-authorship network connecting the top 25 collaborators of C.M. Pirie. A scholar is included among the top collaborators of C.M. Pirie based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with C.M. Pirie. C.M. Pirie is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

15 of 15 papers shown

Pan, Lydia C., Philip A. Carpino, Bruce A. Lefker, et al.. (2001). Preclinical Pharmacology of CP-424,391, an Orally Active Pyrazolidinone-Piperidine Growth Hormone Secretagogue. Endocrine. 14(1). 121–132. 33 indexed citations

Gay, David M., Lydia C. Pan, Jennifer W. Hendrick, et al.. (2001). Treatment With a Growth Hormone Secretagogue in a Model of Developing Heart Failure. Circulation. 103(2). 308–313. 37 indexed citations

Ke, Hua Zhu, David T. Crawford, Hongyi Qi, et al.. (1999). Droloxifene does not blunt bone anabolic effects of prostaglandin E2, but maintains prostaglandin E2-restored bone in aged, ovariectomized rats. Bone. 24(1). 41–47. 12 indexed citations

Houck, Ward V., Lydia C. Pan, Scott B. Kribbs, et al.. (1999). Effects of Growth Hormone Supplementation on Left Ventricular Morphology and Myocyte Function With the Development of Congestive Heart Failure. Circulation. 100(19). 2003–2009. 45 indexed citations

Ke, H.Z., V. Shen, Hongyi Qi, et al.. (1998). Prostaglandin E2 increases bone strength in intact rats and in ovariectomized rats with established osteopenia. Bone. 23(3). 249–255. 47 indexed citations

Simmons, Hollis A., C.M. Pirie, David D. Thompson, & Hua Zhu Ke. (1998). Parathyroid Hormone (1–34) Increased Total Body Bone Mass in Aged Female Rats. Journal of Pharmacology and Experimental Therapeutics. 286(1). 341–344. 11 indexed citations

Ke, Hua Zhu, Vishwas Paralkar, W A Grasser, et al.. (1998). Effects of CP-336,156, a New, Nonsteroidal Estrogen Agonist/Antagonist, on Bone, Serum Cholesterol, Uterus, and Body Composition in Rat Models. Endocrinology. 139(4). 2068–2076. 121 indexed citations

Spinale, F. G., Ward V. Houck, Scott B. Kribbs, et al.. (1998). Growth hormone supplementation with developing congestive heart failure Effects on left ventricular cellular structure and composition. 180. 1 indexed citations

Ke, Hua Zhu, Hollis A. Simmons, Hongyi Qi, et al.. (1997). Comparative effects of droloxifene, tamoxifen, and estrogen on bone, serum cholesterol, and uterine histology in the ovariectomized rat model. Bone. 20(1). 31–39. 111 indexed citations

10.

Qi, Hongyi, et al.. (1996). Longitudinal and cross-sectional characterization of long-term skeletal effects of aging and orchidectomy in the male rat. Bone. 19(3). 146–146. 2 indexed citations

11.

Ke, Hua Zhu, Y.F. Ma, Hongyi Qi, et al.. (1995). Droloxifene inhibits cortical bone turnover associated with estrogen deficiency in rats. Bone. 17(4). S175–S179. 16 indexed citations

12.

Thompson, David D., Hollis A. Simmons, C.M. Pirie, & H.Z. Ke. (1995). FDA guidelines and animal models for osteoporosis. Bone. 17(4). S125–S133. 385 indexed citations

13.

Ke, H.Z., Hongyi Qi, C.M. Pirie, et al.. (1995). Effects of droloxifene on prevention of cancellous bone loss and bone turnover in the axial skeleton of aged, ovariectomized rats. Bone. 17(5). 491–496. 35 indexed citations

14.

Ke, H.Z., Hollis A. Simmons, C.M. Pirie, David T. Crawford, & David D. Thompson. (1995). Droloxifene, a new estrogen antagonist/agonist, prevents bone loss in ovariectomized rats.. Endocrinology. 136(6). 2435–2441. 97 indexed citations

15.

Ke, Hua Zhu, et al.. (1995). Droloxifene prevents ovariectomy-induced bone loss in tibiae and femora of aged female rats: A dual-energy X-ray absorptiometric and histomorphometric study. Journal of Bone and Mineral Research. 10(8). 1256–1262. 33 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact